|
|
fibrinolysis
|
GO:0042730 |
3 |
0.507
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.476
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.461
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.376
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.370
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.338
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.313
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.299
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.297
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.283
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.277
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.242
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.226
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.222
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.222
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.218
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.202
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.201
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.199
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.185
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.182
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.169
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.167
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.167
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.162
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.161
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.154
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.153
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.152
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.151
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.150
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.146
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.130
|
|
|
|
progesterone biosynthetic process
|
GO:0006701 |
1 |
0.124
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.121
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.120
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.118
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.116
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.105
|
|
|
|
glucuronate metabolic process
|
GO:0019585 |
2 |
0.103
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.101
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.099
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.096
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.090
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.090
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.089
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.088
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.088
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.088
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.087
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.087
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.085
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.085
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.083
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.082
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.081
|
|
|
|
regulation of estrogen secretion
|
GO:2000861 |
1 |
0.080
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.080
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.079
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.078
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.078
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.076
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.074
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.073
|
|
|
|
negative regulation of iron ion transport
|
GO:0034757 |
1 |
0.073
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.072
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.071
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.071
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.070
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.069
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.069
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.068
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.067
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.067
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.067
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.066
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.066
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.066
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.065
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.064
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.064
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.063
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.063
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.062
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.061
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.061
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.061
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.059
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.059
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.059
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.059
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.059
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.059
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.058
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.058
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.056
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.056
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.056
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.055
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.055
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.054
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.054
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.054
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.054
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.054
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.053
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.052
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.052
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.052
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.052
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.051
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.051
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.050
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.050
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.050
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.049
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.049
|
|
|
|
regulation of complement activation classical pathway
|
GO:0030450 |
1 |
0.049
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.049
|
|
|
|
aromatic amino acid family catabolic process
|
GO:0009074 |
4 |
0.049
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.048
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.048
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.048
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.047
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.047
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.046
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.046
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.046
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.046
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.045
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.045
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.045
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.045
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.044
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.044
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.044
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.043
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.043
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.043
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.042
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.042
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.042
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.041
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.041
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.041
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.041
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.040
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.040
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.040
|
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.040
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.040
|
|
|
|
plasminogen activation
|
GO:0031639 |
7 |
0.040
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.040
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.040
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.039
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.039
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.039
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.039
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.039
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.039
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.039
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.039
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.039
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.038
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.038
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.038
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.038
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.038
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.038
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.037
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.037
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.037
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.037
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.036
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.036
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.036
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.036
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.036
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.036
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.036
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.035
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.035
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.035
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.035
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.035
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.035
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.035
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.034
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.034
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.034
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.034
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.034
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.034
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.034
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.034
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.033
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.033
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.033
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.033
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.033
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.033
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.033
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.033
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.032
|
|
|
|
response to cadmium ion
|
GO:0046686 |
8 |
0.032
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.032
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.032
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.031
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.031
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.030
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.030
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.030
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.030
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.030
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.030
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.030
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.030
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.030
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.030
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.030
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.030
|
|
|
|
bile acid and bile salt transport
|
GO:0015721 |
5 |
0.030
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.030
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.030
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.029
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.029
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.029
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.029
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.029
|
|
|
|
positive regulation of systemic arterial blood pressure
|
GO:0003084 |
9 |
0.029
|
|
|
|
uronic acid metabolic process
|
GO:0006063 |
2 |
0.029
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.029
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.028
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.028
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.028
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.028
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.028
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.028
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.028
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
negative regulation of cell adhesion mediated by integrin
|
GO:0033629 |
2 |
0.028
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.028
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.027
|
|
|
|
amino acid betaine transport
|
GO:0015838 |
3 |
0.027
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.027
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.027
|
|
|
|
medium chain fatty acid metabolic process
|
GO:0051791 |
1 |
0.027
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.027
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.027
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.027
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.027
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.027
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.026
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.026
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.026
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.026
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.026
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.026
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.026
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.026
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.026
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.025
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.025
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.025
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.025
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.025
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.025
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.025
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.025
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.025
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.025
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.025
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.025
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.025
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.024
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.024
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.024
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.024
|
|
|
|
glycolytic process
|
GO:0006096 |
20 |
0.024
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.024
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.024
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.024
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.024
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.023
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.023
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.023
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
12 |
0.023
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.023
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.023
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.023
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.023
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.023
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.023
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.023
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.022
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.022
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.022
|
|
|
|
drug transmembrane transport
|
GO:0006855 |
5 |
0.022
|
|
|
|
ketone body metabolic process
|
GO:1902224 |
3 |
0.022
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.022
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.022
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.021
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.021
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.021
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.021
|
|
|
|
folic acid containing compound metabolic process
|
GO:0006760 |
3 |
0.021
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.021
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.021
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.021
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.021
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.021
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.021
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.021
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.020
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.020
|
|
|
|
diterpenoid biosynthetic process
|
GO:0016102 |
7 |
0.020
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.020
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.020
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.020
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.020
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.020
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.020
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.020
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.020
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.020
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.020
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.020
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.019
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.019
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.019
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.019
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.019
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.019
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.019
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.019
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.019
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.019
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.019
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.018
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.018
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.018
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.018
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.018
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.018
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.018
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.018
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.018
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.018
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.018
|
|
|
|
leydig cell differentiation
|
GO:0033327 |
10 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.018
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.018
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.018
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.018
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.018
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.018
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.017
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.017
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.017
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.017
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.017
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.017
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.017
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.017
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.017
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.017
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.017
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.017
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.017
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.017
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.017
|
|
|
|
9 cis retinoic acid metabolic process
|
GO:0042905 |
5 |
0.017
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.017
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.017
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.016
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.016
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.016
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.016
|
|
|
|
toxin metabolic process
|
GO:0009404 |
5 |
0.016
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.016
|
|
|
|
c21 steroid hormone metabolic process
|
GO:0008207 |
7 |
0.016
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.016
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.016
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.016
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.016
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.016
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.016
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.016
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.016
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.016
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.016
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.016
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.016
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.016
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.016
|
|
|
|
retinoic acid biosynthetic process
|
GO:0002138 |
7 |
0.016
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.016
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.016
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.016
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.015
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.015
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.015
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.015
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.015
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.015
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.015
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.015
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.015
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
|
xenobiotic transport
|
GO:0042908 |
1 |
0.015
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.015
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.015
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.015
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.015
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.015
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.015
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.015
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.015
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.015
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.015
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.014
|
|
|
|
glutamine family amino acid metabolic process
|
GO:0009064 |
15 |
0.014
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.014
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.014
|
|
|
|
urea transmembrane transport
|
GO:0071918 |
2 |
0.014
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.014
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.014
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.014
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.014
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.014
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.014
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.014
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.014
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.014
|
|